Cargando…

Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021

PURPOSE: Interventional procedures have become a mainstay in the therapy of acute limb ischemia caused by embolism or arterial thrombosis. Treatment options include pharmacological thrombolysis (PT) and mechanical thrombectomy (MT). The aim of this study was to evaluate success and major complicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastian, Moritz B., Nadjiri, Jonathan, Wessendorf, Joel, Scheschenja, Michael, König, Alexander M., Jedelska, Jarmila, Mahnken, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460325/
https://www.ncbi.nlm.nih.gov/pubmed/37632599
http://dx.doi.org/10.1186/s42155-023-00393-8
_version_ 1785097618972475392
author Bastian, Moritz B.
Nadjiri, Jonathan
Wessendorf, Joel
Scheschenja, Michael
König, Alexander M.
Jedelska, Jarmila
Mahnken, Andreas H.
author_facet Bastian, Moritz B.
Nadjiri, Jonathan
Wessendorf, Joel
Scheschenja, Michael
König, Alexander M.
Jedelska, Jarmila
Mahnken, Andreas H.
author_sort Bastian, Moritz B.
collection PubMed
description PURPOSE: Interventional procedures have become a mainstay in the therapy of acute limb ischemia caused by embolism or arterial thrombosis. Treatment options include pharmacological thrombolysis (PT) and mechanical thrombectomy (MT). The aim of this study was to evaluate success and major complication rates of interventional radiological treatments of arterial embolism and thrombosis in Germany in 2021 and to compare their results with accepted international quality standards. MATERIALS AND METHODS: Data for PT and MT for 2021 was obtained from the quality management system of the German interventional radiological society (DeGIR). 2431 PT and 1582 MT procedures were documented for 2021, with 459 combinations of PT and MT. Data was analysed for technical and clinical success rates, as well as major complication rates such as intracranial bleeding, major bleeding, distal embolization, aneurysm formation, organ-failure and cardiac-decompensation. RESULTS: PT alone had technical and clinical success rate of 90.21% and 81.08%, respectively. MT alone had technical and clinical success rates of 97.41% and 95.39%, respectively. MT&PT had technical and clinical success rates of 91.07% and 84.75%, respectively. Major complications were: distal embolization (PT:2.02%; MT:1.74%; PT&MT:2.61%), major bleeding (PT:0.94%; MT:1.14%; PT&MT:0.87%), aneurysm formation (PT:0.33%;MT: 1.14%;PT&MT: 0%), intracranial bleeding (PT:0.16%;MT:0%;PT&MT:0.22%), cardiac-decompensation (PT:0.21%;MT: 0.06%;PT&MT:0%) and organ-failure (PT:0%;MT:0.06%;PT&MT:0.22%). Technical and clinical success rates were higher, while complication rates were lower than the corresponding threshold recommended by the Society of Interventional Radiology for percutaneous management of acute lower-extremity ischemia. CONCLUSION: Treatment of arterial embolism and thrombosis performed by interventional radiologists in Germany is effective and safe with outcomes exceeding internationally accepted standards.
format Online
Article
Text
id pubmed-10460325
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-104603252023-08-28 Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021 Bastian, Moritz B. Nadjiri, Jonathan Wessendorf, Joel Scheschenja, Michael König, Alexander M. Jedelska, Jarmila Mahnken, Andreas H. CVIR Endovasc Original Article PURPOSE: Interventional procedures have become a mainstay in the therapy of acute limb ischemia caused by embolism or arterial thrombosis. Treatment options include pharmacological thrombolysis (PT) and mechanical thrombectomy (MT). The aim of this study was to evaluate success and major complication rates of interventional radiological treatments of arterial embolism and thrombosis in Germany in 2021 and to compare their results with accepted international quality standards. MATERIALS AND METHODS: Data for PT and MT for 2021 was obtained from the quality management system of the German interventional radiological society (DeGIR). 2431 PT and 1582 MT procedures were documented for 2021, with 459 combinations of PT and MT. Data was analysed for technical and clinical success rates, as well as major complication rates such as intracranial bleeding, major bleeding, distal embolization, aneurysm formation, organ-failure and cardiac-decompensation. RESULTS: PT alone had technical and clinical success rate of 90.21% and 81.08%, respectively. MT alone had technical and clinical success rates of 97.41% and 95.39%, respectively. MT&PT had technical and clinical success rates of 91.07% and 84.75%, respectively. Major complications were: distal embolization (PT:2.02%; MT:1.74%; PT&MT:2.61%), major bleeding (PT:0.94%; MT:1.14%; PT&MT:0.87%), aneurysm formation (PT:0.33%;MT: 1.14%;PT&MT: 0%), intracranial bleeding (PT:0.16%;MT:0%;PT&MT:0.22%), cardiac-decompensation (PT:0.21%;MT: 0.06%;PT&MT:0%) and organ-failure (PT:0%;MT:0.06%;PT&MT:0.22%). Technical and clinical success rates were higher, while complication rates were lower than the corresponding threshold recommended by the Society of Interventional Radiology for percutaneous management of acute lower-extremity ischemia. CONCLUSION: Treatment of arterial embolism and thrombosis performed by interventional radiologists in Germany is effective and safe with outcomes exceeding internationally accepted standards. Springer International Publishing 2023-08-26 /pmc/articles/PMC10460325/ /pubmed/37632599 http://dx.doi.org/10.1186/s42155-023-00393-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Bastian, Moritz B.
Nadjiri, Jonathan
Wessendorf, Joel
Scheschenja, Michael
König, Alexander M.
Jedelska, Jarmila
Mahnken, Andreas H.
Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021
title Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021
title_full Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021
title_fullStr Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021
title_full_unstemmed Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021
title_short Safety and efficacy of interventional treatment of acute limb ischemia in Germany 2021
title_sort safety and efficacy of interventional treatment of acute limb ischemia in germany 2021
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460325/
https://www.ncbi.nlm.nih.gov/pubmed/37632599
http://dx.doi.org/10.1186/s42155-023-00393-8
work_keys_str_mv AT bastianmoritzb safetyandefficacyofinterventionaltreatmentofacutelimbischemiaingermany2021
AT nadjirijonathan safetyandefficacyofinterventionaltreatmentofacutelimbischemiaingermany2021
AT wessendorfjoel safetyandefficacyofinterventionaltreatmentofacutelimbischemiaingermany2021
AT scheschenjamichael safetyandefficacyofinterventionaltreatmentofacutelimbischemiaingermany2021
AT konigalexanderm safetyandefficacyofinterventionaltreatmentofacutelimbischemiaingermany2021
AT jedelskajarmila safetyandefficacyofinterventionaltreatmentofacutelimbischemiaingermany2021
AT mahnkenandreash safetyandefficacyofinterventionaltreatmentofacutelimbischemiaingermany2021